Position in SCLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$652
-$13,353 QoQ
Shares Held
98
-91.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026OSAIC HOLDINGS, INC. holds $1,074,582,991 across 20 Drug Manufacturers - General names. SCLX ranks #20 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
312,761 | $287,668,182 | |
| 2 | JNJ |
Johnson & Johnson
|
837,314 | $204,673,032 | |
| 3 | ABBV |
AbbVie Inc.
|
726,921 | $158,098,046 | |
| 4 | MRK |
Merck & Co., Inc.
|
827,246 | $99,509,419 | |
| 5 | AMGN |
Amgen Inc
|
272,668 | $95,938,235 | |
| 6 | PFE |
Pfizer Inc
|
2,374,689 | $66,681,266 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
827,253 | $50,172,893 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
254,507 | $35,470,638 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $652 | 98 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $14,005 | 1,148 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,545 | 231 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,365 | 232 | Shares | Defined | 2025-09-04 | |
| No filing history on record for this holder in this stock. | ||||||